Dr. Pass on the Challenges of Treating Mesothelioma

Harvey I. Pass, MD
Published: Friday, Aug 23, 2013

Harvey I. Pass, MD, Stephen E. Banner Professor of Thoracic Oncology, Vice-Chair Research, Department of Cardiothoracic Surgery, Division Chief, General Thoracic Surgery, NYU Langone Medical Center, discusses the challenges of treating patients with mesothelioma.

Mesothelioma is a notorious disease of elderly people, Pass says, and symptoms may go unnoticed or develop slowly. Additionally, a delay in treatment could arise. Pass says that only about 20% of patients with mesothelioma are seen that may be good surgical candidates for a multimodality treatment.

It remains important to find the disease earlier, when effective treatment may have a chance.

Harvey I. Pass, MD, Stephen E. Banner Professor of Thoracic Oncology, Vice-Chair Research, Department of Cardiothoracic Surgery, Division Chief, General Thoracic Surgery, NYU Langone Medical Center, discusses the challenges of treating patients with mesothelioma.

Mesothelioma is a notorious disease of elderly people, Pass says, and symptoms may go unnoticed or develop slowly. Additionally, a delay in treatment could arise. Pass says that only about 20% of patients with mesothelioma are seen that may be good surgical candidates for a multimodality treatment.

It remains important to find the disease earlier, when effective treatment may have a chance.




View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Medical Crossfire®: Key Questions for the Use of Immunotherapy Throughout the Disease Continuum for NSCLC in an Era of Rapid DevelopmentSep 29, 20181.5
Provider and Caregiver Connection™: Addressing Patient Concerns While Managing GlioblastomaSep 29, 20182.0
Publication Bottom Border
Border Publication
x